Xuejun H Parsons
Overview
Explore the profile of Xuejun H Parsons including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
265
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Parsons X
Annu Res Rev Biol
. 2014 Oct;
3(4):323-349.
PMID: 25309947
It has been recognized that pluripotent human embryonic stem cells (hESCs) must be transformed into fate-restricted derivatives before use for cell therapy. Realizing the therapeutic potential of pluripotent hESC derivatives...
2.
Parsons X
Br Biotechnol J
. 2014 Jun;
3(4):424-457.
PMID: 24926434
To date, the lack of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing safe and effective cell-based therapies for...
3.
Parsons X
Methods Mol Biol
. 2014 Feb;
1307:299-318.
PMID: 24500898
Developing novel strategies for well-controlled efficiently directing pluripotent human embryonic stem cells (hESCs) exclusively and uniformly towards clinically relevant cell types in a lineage-specific manner is not only crucial for...
4.
Parsons X
J Regen Med
. 2013 Aug;
1(2).
PMID: 23936871
The growing number of identified stem cell derivatives and escalating concerns for safety and efficacy of these cells towards clinical applications have made it increasingly crucial to be able to...
5.
Parsons X, Parsons J, Moore D
Mol Med Ther
. 2013 Apr;
1(2).
PMID: 23543894
To date, lacking of a clinically-suitable source of engraftable human stem/progenitor cells with adequate neurogenic potential has been the major setback in developing effective cell-based therapies against a wide range...
6.
Parsons X
Anat Physiol
. 2013 Apr;
(S3).
PMID: 23543848
Pluripotent Human Embryonic Stem Cells (hESCs) have the unconstrained capacity for long-term stable undifferentiated growth in culture and unrestricted developmental capacity. Packaging of the eukaryotic genome into chromatin confers higher...
7.
Parsons X
J Regen Med Tissue Eng
. 2013 Apr;
1(1).
PMID: 23542901
Background: Pluripotent human embryonic stem cells (hESCs) proffer cures for a wide range of neurological disorders by supplying the diversity of human neuronal cell types in the developing CNS for...
8.
Parsons X, Teng Y, Moore D, Snyder E
Recent Pat Regen Med
. 2013 Jan;
1(2):142-163.
PMID: 23355961
Human embryonic stem cells (hESCs) are genetically stable with unlimited expansion ability and unrestricted plasticity, proffering a pluripotent reservoir for in vitro derivation of a large supply of disease-targeted human...
9.
Parsons X
J Stem Cell Res Ther
. 2013 Jan;
2(3).
PMID: 23355957
Realizing the potential of human embryonic stem cells (hESCs) has been hindered by the inefficiency and instability of generating desired cell types from pluripotent cells through multi-lineage differentiation. We recently...
10.
Parsons J, Smotrich D, Gonzalez R, Snyder E, Moore D, Parsons X
J Clin Exp Cardiolog
. 2012 Aug;
S9.
PMID: 22905333
To date, lacking of a clinically-suitable human cardiac cell source with adequate myocardium regenerative potential has been the major setback in regenerating the damaged human myocardium. Pluripotent Human Embryonic Stem...